Citation: | QUAN Xin-xin, YU Jie-ping, WANG Ping. Analysis of CDKN2 Gene Alterations in Human Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(5): 348-350. |
[1] |
Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types.Science,1994,264:436~440
|
[2] |
Serrano M,Hnnon GJ,Beach D,et al.A new regulatory motifin cellcycle control causing specific inhibition of cyclin D/CDK4. Nature,1993,366:704~707
|
[3] |
Nobori T,Miura K,Wu DJ,et al.Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.Nature,1993,368:75 ~756
|
[4] |
Liu Q,Yan YX,McClure M,et al.MTS-1(CDKN2)tumor suppressor gene deletion are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.Oncogene,1995,19(1):1061~1067
|
[5] |
Mao L,Merlo A,Bedi G,et al.A novel p16NK4A transcript.Cancer Res,1995,55:2995~2997
|
[6] |
Sakata K,Tamura G,Maesawa C,et al.Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas.Jpn J.Cancer Res,1995,86:333~335
|
[7] |
Igaki H,Sasaki H,Tachimori Y,et al.Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract.Cancer Res,1995,55:3421~3423
|